TERMIUM Plus®

The Government of Canada’s terminology and linguistic data bank.

BISPHOSPHONATE [1 record]

Record 1 1997-06-03

English

Subject field(s)
  • Pharmacology
CONT

In addition to considering some of the conventional therapeutic approaches, a rationale for the use of bone resorption inhibitors, such as the diphosphonates (bisphosphonates), is presented for the prevention and amelioration of the pathologic consequences of skeletal metastases. ["Bone metastases: pathogenesis, treatment, and rationale for use of resorption inhibitors", Scher HI Yagoda A. In: Am J Med (1987 Feb 23) 82(2A):6-28]*

CONT

Clodronate: - Discussion: - one of the first bisphosphonates used to treat patients with cancer-related hypercalcemia; [<a href="http://www.medmedia.com/o15/65.htm" title="http://www.medmedia.com/o15/65.htm">http://www.medmedia.com/o15/65.htm</a>]

French

Domaine(s)
  • Pharmacologie
CONT

Le pamidronate appartient à la classe des bisphosphonates (anciennement appelés diphosphonates), inhibiteurs de la résorption osseuse.

OBS

Selon la source d, «diphosphonate» est un terme vieilli. D'autres monographies du CPS utilisent ce terme sans cette précision.

Spanish

Save record 1

Copyright notice for the TERMIUM Plus® data bank

© Public Services and Procurement Canada, 2024
TERMIUM Plus®, the Government of Canada's terminology and linguistic data bank
A product of the Translation Bureau

Features

Language Portal of Canada

Access a collection of Canadian resources on all aspects of English and French, including quizzes.

Writing tools

The Language Portal’s writing tools have a new look! Easy to consult, they give you access to a wealth of information that will help you write better in English and French.

Glossaries and vocabularies

Access Translation Bureau glossaries and vocabularies.

Date Modified: